EcoDrugPlus

Cholinergic Receptor Muscarinic 3

Ensembl ID : ENSDLAG00005030699
Gene Symbol: CHRM3
1 Cross references
188 Possible Orthologues:

Cholinergic Receptor Muscarinic 4

Ensembl ID : ENSDLAG00005007732
Gene Symbol: CHRM4
1 Cross references
186 Possible Orthologues:

Cholinergic Receptor Muscarinic 5

Ensembl ID : ENSDLAG00005006443
Gene Symbol: CHRM5
1 Cross references
195 Possible Orthologues:

Cholinergic Receptor Nicotinic Beta 4 Subunit

Ensembl ID : ENSDLAG00005010509
Gene Symbol: CHRNB4
1 Cross references
194 Possible Orthologues:

Cholinergic Receptor, Muscarinic 2a

Ensembl ID : ENSDLAG00005032814
Gene Symbol: CHRM2A
1 Cross references
196 Possible Orthologues:

Cholinergic Receptor, Muscarinic 5b

Ensembl ID : ENSDLAG00005031046
Gene Symbol: CHRM5B
1 Cross references
190 Possible Orthologues:

Coagulation Factor Ii Thrombin Receptor 2.1

Ensembl ID : ENSDLAG00005022061
Gene Symbol: F2R2.1
1 Cross references
265 Possible Orthologues:

Coagulation Factor Iiia

Ensembl ID : ENSDLAG00005016611
Gene Symbol: F3A
1 Cross references
199 Possible Orthologues:

Coagulation Factor X

Ensembl ID : ENSDLAG00005017753
Gene Symbol: F10
1 Cross references
246 Possible Orthologues:

Coiled-Coil Domain Containing 6

Ensembl ID : ENSDLAG00005034209
Gene Symbol: CCDC6
1 Cross references
208 Possible Orthologues:

Colony Stimulating Factor 1 Receptor, A

Ensembl ID : ENSDLAG00005008193
Gene Symbol: CSF1RA
1 Cross references
207 Possible Orthologues:

Cyclin Dependent Kinase 6

Ensembl ID : ENSDLAG00005018467
Gene Symbol: CDK6
1 Cross references
200 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).